Stuart Naylor
Insider (Form 4 reporting owner): CHIEF SCI OFCR, OPHTHALMOLOGY CIK 1742771Name as filed: Naylor StuartIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 18 Feb 2020, sold $2.5M in 16 sales (3 under a 10b5-1 plan set in advance) of MeiraGTx.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| MeiraGTx MGTX | CHIEF SCI OFCR, OPHTHALMOLOGY | 18 Feb 2020 | 6 Oct 2026 | – | 16$2.5M |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After sales | -22.3 pts13 trades, 7.7% above the sector | -54.9 pts12 trades, 0.00% above the sector | -69.8 pts11 trades, 0.00% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | – | – | 3 | $963K | -$963K |
| 2021 | – | – | 6 | $761K | -$761K |
| 2020 | – | – | 7 | $744K | -$744K |
Every trade
18, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 6 Oct 2026 | MeiraGTx MGTX | Sell | 27,659 | $10.64 | $294K | 10b5-1 plan | Form 4filed 6 Oct 2026 |
| 7 Jul 2026 | MeiraGTx MGTX | Sell | 27,659 | $14.80 | $409K | 10b5-1 plan | Form 4filed 7 Jul 2026 |
| 7 Apr 2026 | MeiraGTx MGTX | Sell | 27,661 | $9.36 | $259K | 10b5-1 plan | Form 4filed 7 Apr 2026 |
| 18 Oct 2021 | MeiraGTx MGTX | Sell | 12,000 | $17.95 | $215K | Not stated | Form 4filed 20 Oct 2021 |
| 20 Jul 2021 | MeiraGTx MGTX | Sell | 9,390 | $15.06 | $141K | Not stated | Form 4filed 21 Jul 2021 |
| 13 Jul 2021 | MeiraGTx MGTX | Sell | 2,610 | $15.04 | $39K | Not stated | Form 4filed 15 Jul 2021 |
| 7 Jun 2021 | MeiraGTx MGTX | Sell | 6,082 | $15.01 | $91K | Not stated | Form 4filed 9 Jun 2021 |
| 28 Apr 2021 | MeiraGTx MGTX | Sellamended filing (4/A), not counted again; the same trade was reported by another filer; counted there | 0 | Not filed | Not filed | Not stated | Form 4/Afiled 30 Apr 2021 |
| 28 Apr 2021 | MeiraGTx MGTX | Sell | 5,918 | $15.10 | $89K | Not stated | Form 4filed 30 Apr 2021 |
| 4 Jan 2021 | MeiraGTx MGTX | Sell | 12,000 | $15.37 | $184K | Not stated | Form 4filed 6 Jan 2021 |
| 10 Nov 2020 | MeiraGTx MGTX | Sellamended filing (4/A), not counted again | 4,851 | $15.00 | $73K | Not stated | Form 4/Afiled 6 Jan 2021 |
| 10 Nov 2020 | MeiraGTx MGTX | Sell | 3,739 | $15.00 | $56K | Not stated | Form 4filed 12 Nov 2020 |
| 5 Nov 2020 | MeiraGTx MGTX | Sell | 8,794 | $15.02 | $132K | Not stated | Form 4filed 9 Nov 2020 |
| 5 Oct 2020 | MeiraGTx MGTX | Sell | 301 | $15.00 | $5K | Not stated | Form 4filed 7 Oct 2020 |
| 20 Jul 2020 | MeiraGTx MGTX | Sell | 10,054 | $15.03 | $151K | Not stated | Form 4filed 22 Jul 2020 |
| 11 May 2020 | MeiraGTx MGTX | Sell | 11,304 | $15.39 | $174K | Not stated | Form 4filed 13 May 2020 |
| 20 Apr 2020 | MeiraGTx MGTX | Sell | 696 | $15.00 | $10K | Not stated | Form 4filed 22 Apr 2020 |
| 18 Feb 2020 | MeiraGTx MGTX | Sell | 12,000 | $17.96 | $216K | Not stated | Form 4filed 20 Feb 2020 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.